Skip to main content
Erschienen in: Acta Neurochirurgica 5/2016

09.03.2016 | Experimental Research - Functional

Effects of quercetin on chronic constriction nerve injury in an experimental rat model

verfasst von: Soner Çivi, Gökçen Emmez, Ümit Akın Dere, Alp Özgün Börcek, Hakan Emmez

Erschienen in: Acta Neurochirurgica | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Flavonoids are popular substances in the literature, with proven effects on cardiovascular, neoplastic and neurodegenerative diseases. Antioxidant effect is the most pronounced and studied one. Among thousands of flavonoids, quercetin (QUE) is a prototype with significant antioxidant effects. This study aims to demonstrate the effects of QUE in an experimental rat model of chronic constriction injury (CCI).

Method

A two-level study was designed with 42 adult Wistar rats that were randomly assigned to different groups. In the first part, animals in sham, control, quercetin, morphine and gabapentine groups received chronic constriction injury to their sciatic nerves and received a single dose of QUE, morphine and gabapentine. In the second part, different dose regimens of QUE were administered to different groups of animals. Pre-injury and post-injury assessments for mechanical hypersensitivity, thermal sensitivity, locomotor activity and anxiety were recorded and statistical comparisons were performed between different groups.

Results

Comparison of QUE with morphine and gabapentine has revealed significant effects of this agent in the current chronic constriction injury model. QUE was significantly superior to Gabapentine and morphine in terms of alleviating mechanical and thermal hypersensitivity. Additionally, pre-injury administration of QUE for 4 days demonstrated long-term effectiveness on mechanical hypersensitivity.

Conclusions

This preliminary report the on effects of QUE in a chronic constriction injury model proved significant effects of the agent, which should be supplemented with different studies using different dose regimens.
Literatur
1.
Zurück zum Zitat Anjaneyulu M, Chopra K (2003) Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Prog Neuro-Psychopharmacol Biol Psychiatry 27:1001–1005CrossRef Anjaneyulu M, Chopra K (2003) Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Prog Neuro-Psychopharmacol Biol Psychiatry 27:1001–1005CrossRef
2.
Zurück zum Zitat Anjaneyulu M, Chopra K (2004) Quercetin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats. Indian J Exp Biol 42:766–769PubMed Anjaneyulu M, Chopra K (2004) Quercetin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats. Indian J Exp Biol 42:766–769PubMed
3.
Zurück zum Zitat Arcos M, Palanca JM, Montes F, Barrios C (2013) Antioxidants and gabapentin prevent heat hypersensitivity in a neuropathic pain model. J Investig Surg 26:109–117CrossRef Arcos M, Palanca JM, Montes F, Barrios C (2013) Antioxidants and gabapentin prevent heat hypersensitivity in a neuropathic pain model. J Investig Surg 26:109–117CrossRef
4.
Zurück zum Zitat Bennett GJ, Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87–107CrossRefPubMed Bennett GJ, Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87–107CrossRefPubMed
5.
Zurück zum Zitat Coderre TJ, Kumar N, Lefebvre CD, Yu JSC (2007) A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain. J Neurochem 100:1289–1299CrossRefPubMed Coderre TJ, Kumar N, Lefebvre CD, Yu JSC (2007) A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain. J Neurochem 100:1289–1299CrossRefPubMed
6.
Zurück zum Zitat Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, Galvez J, Zarzuelo A (2005) In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 35:584–592CrossRefPubMed Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, Galvez J, Zarzuelo A (2005) In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 35:584–592CrossRefPubMed
7.
Zurück zum Zitat De Vry J, Kuhl E, Franken-Kunkel P, Eckel G (2004) Pharmacological characterization of the chronic constriction injury model of neuropathic pain. Eur J Pharmacol 491:137–148CrossRefPubMed De Vry J, Kuhl E, Franken-Kunkel P, Eckel G (2004) Pharmacological characterization of the chronic constriction injury model of neuropathic pain. Eur J Pharmacol 491:137–148CrossRefPubMed
8.
Zurück zum Zitat Dworkin RH (2002) An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain 18:343–349CrossRefPubMed Dworkin RH (2002) An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain 18:343–349CrossRefPubMed
9.
Zurück zum Zitat Filho AW, Filho VC, Olinger L, de Souza MM (2008) Quercetin: further investigation of its antinociceptive properties and mechanisms of action. Arch Pharm Res 31:713–721CrossRefPubMed Filho AW, Filho VC, Olinger L, de Souza MM (2008) Quercetin: further investigation of its antinociceptive properties and mechanisms of action. Arch Pharm Res 31:713–721CrossRefPubMed
10.
Zurück zum Zitat Fundytus ME (2001) Glutamate receptors and nociception: implications for the drug treatment of pain. CNS Drugs 15:29–58CrossRefPubMed Fundytus ME (2001) Glutamate receptors and nociception: implications for the drug treatment of pain. CNS Drugs 15:29–58CrossRefPubMed
11.
Zurück zum Zitat Hara K, Haranishi Y, Kataoka K, Takahashi Y, Terada T, Nakamura M, Sata T (2014) Chlorogenic acid administered intrathecally alleviates mechanical and cold hyperalgesia in a rat neuropathic pain model. Eur J Pharmacol 723:459–464CrossRefPubMed Hara K, Haranishi Y, Kataoka K, Takahashi Y, Terada T, Nakamura M, Sata T (2014) Chlorogenic acid administered intrathecally alleviates mechanical and cold hyperalgesia in a rat neuropathic pain model. Eur J Pharmacol 723:459–464CrossRefPubMed
12.
Zurück zum Zitat Hara K, Nakamura M, Haranishi Y, Terada T, Kataoka K, Sata T (2012) Antinociceptive effect of intrathecal administration of hypotaurine in rat models of inflammatory and neuropathic pain. Amino Acids 43:397–404CrossRefPubMed Hara K, Nakamura M, Haranishi Y, Terada T, Kataoka K, Sata T (2012) Antinociceptive effect of intrathecal administration of hypotaurine in rat models of inflammatory and neuropathic pain. Amino Acids 43:397–404CrossRefPubMed
13.
Zurück zum Zitat Hopkins SC, Zhao FY, Bowen CA, Fang X, Wei H, Heffernan ML, Spear KL, Spanswick DC, Varney MA, Large TH (2013) Pharmacodynamic effects of a D-amino acid oxidase inhibitor indicate a spinal site of action in rat models of neuropathic pain. J Pharmacol Exp Ther 345:502–511CrossRefPubMed Hopkins SC, Zhao FY, Bowen CA, Fang X, Wei H, Heffernan ML, Spear KL, Spanswick DC, Varney MA, Large TH (2013) Pharmacodynamic effects of a D-amino acid oxidase inhibitor indicate a spinal site of action in rat models of neuropathic pain. J Pharmacol Exp Ther 345:502–511CrossRefPubMed
14.
Zurück zum Zitat Ishisaka A, Ichikawa S, Sakakibara H, Piskula MK, Nakamura T, Kato Y, Ito M, K-i M, Tsuji A, Kawai Y, Terao J (2011) Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. Free Radic Biol Med 51:1329–1336CrossRefPubMed Ishisaka A, Ichikawa S, Sakakibara H, Piskula MK, Nakamura T, Kato Y, Ito M, K-i M, Tsuji A, Kawai Y, Terao J (2011) Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. Free Radic Biol Med 51:1329–1336CrossRefPubMed
15.
Zurück zum Zitat Maciel RM, Costa MM, Martins DB, França RT, Schmatz R, Graça DL, Duarte MMMF, Danesi CC, Mazzanti CM, Schetinger MRC, Paim FC, Palma HE, Abdala FH, Stefanello N, Zimpel CK, Felin DV, Lopes STA (2013) Antioxidant and anti-inflammatory effects of quercetin in functional and morphological alterations in streptozotocin-induced diabetic rats. Res Vet Sci 95:389–397CrossRefPubMed Maciel RM, Costa MM, Martins DB, França RT, Schmatz R, Graça DL, Duarte MMMF, Danesi CC, Mazzanti CM, Schetinger MRC, Paim FC, Palma HE, Abdala FH, Stefanello N, Zimpel CK, Felin DV, Lopes STA (2013) Antioxidant and anti-inflammatory effects of quercetin in functional and morphological alterations in streptozotocin-induced diabetic rats. Res Vet Sci 95:389–397CrossRefPubMed
16.
Zurück zum Zitat Manthey JA (2000) Biological properties of flavonoids pertaining to inflammation. Microcirculation 7:S29–S34CrossRefPubMed Manthey JA (2000) Biological properties of flavonoids pertaining to inflammation. Microcirculation 7:S29–S34CrossRefPubMed
17.
Zurück zum Zitat Meisner JG, Marsh AD, Marsh DR (2010) Loss of GABAergic interneurons in laminae I-III of the spinal cord dorsal horn contributes to reduced GABAergic tone and neuropathic pain after spinal cord injury. J Neurotrauma 27:729–737CrossRefPubMed Meisner JG, Marsh AD, Marsh DR (2010) Loss of GABAergic interneurons in laminae I-III of the spinal cord dorsal horn contributes to reduced GABAergic tone and neuropathic pain after spinal cord injury. J Neurotrauma 27:729–737CrossRefPubMed
18.
Zurück zum Zitat Okamoto T (2005) Safety of quercetin for clinical application (review). Int J Mol Med 16:275–278PubMed Okamoto T (2005) Safety of quercetin for clinical application (review). Int J Mol Med 16:275–278PubMed
19.
Zurück zum Zitat Ossola B, Kaariainen TM, Mannisto PT (2009) The multiple faces of quercetin in neuroprotection. Expert Opin Drug Saf 8:397–409CrossRefPubMed Ossola B, Kaariainen TM, Mannisto PT (2009) The multiple faces of quercetin in neuroprotection. Expert Opin Drug Saf 8:397–409CrossRefPubMed
22.
Zurück zum Zitat Quinn LP, Stean TO, Trail B, Duxon MS, Stratton SC, Billinton A, Upton N (2003) LABORAS™: initial pharmacological validation of a system allowing continuous monitoring of laboratory rodent behaviour. J Neurosci Methods 130:83–92CrossRefPubMed Quinn LP, Stean TO, Trail B, Duxon MS, Stratton SC, Billinton A, Upton N (2003) LABORAS™: initial pharmacological validation of a system allowing continuous monitoring of laboratory rodent behaviour. J Neurosci Methods 130:83–92CrossRefPubMed
23.
Zurück zum Zitat Raygude KS, Kandhare AD, Ghosh P, Ghule AE, Bodhankar SL (2012) Evaluation of ameliorative effect of quercetin in experimental model of alcoholic neuropathy in rats. Inflammopharmacology 20:331–341CrossRefPubMed Raygude KS, Kandhare AD, Ghosh P, Ghule AE, Bodhankar SL (2012) Evaluation of ameliorative effect of quercetin in experimental model of alcoholic neuropathy in rats. Inflammopharmacology 20:331–341CrossRefPubMed
24.
Zurück zum Zitat Ro LS, Chang KH (2005) Neuropathic pain: mechanisms and treatments. Chang Gung Med J 28:597–605PubMed Ro LS, Chang KH (2005) Neuropathic pain: mechanisms and treatments. Chang Gung Med J 28:597–605PubMed
25.
Zurück zum Zitat Schultke E, Kendall E, Kamencic H, Ghong Z, Griebel RW, Juurlink BH (2003) Quercetin promotes functional recovery following acute spinal cord injury. J Neurotrauma 20:583–591CrossRefPubMed Schultke E, Kendall E, Kamencic H, Ghong Z, Griebel RW, Juurlink BH (2003) Quercetin promotes functional recovery following acute spinal cord injury. J Neurotrauma 20:583–591CrossRefPubMed
26.
Zurück zum Zitat Song Y, Liu J, Zhang F, Zhang J, Shi T, Zeng Z (2013) Antioxidant effect of quercetin against acute spinal cord injury in rats and its correlation with the p38MAPK/iNOS signaling pathway. Life Sci 92:1215–1221CrossRefPubMed Song Y, Liu J, Zhang F, Zhang J, Shi T, Zeng Z (2013) Antioxidant effect of quercetin against acute spinal cord injury in rats and its correlation with the p38MAPK/iNOS signaling pathway. Life Sci 92:1215–1221CrossRefPubMed
27.
Zurück zum Zitat Terada T, Hara K, Haranishi Y, Sata T (2011) Antinociceptive effect of intrathecal administration of taurine in rat models of neuropathic pain. Can J Anaesth 58:630–637CrossRefPubMed Terada T, Hara K, Haranishi Y, Sata T (2011) Antinociceptive effect of intrathecal administration of taurine in rat models of neuropathic pain. Can J Anaesth 58:630–637CrossRefPubMed
28.
Zurück zum Zitat Theoharides TC (2007) Treatment approaches for painful bladder syndrome/interstitial cystitis. Drugs 67:215–235CrossRefPubMed Theoharides TC (2007) Treatment approaches for painful bladder syndrome/interstitial cystitis. Drugs 67:215–235CrossRefPubMed
29.
Zurück zum Zitat Valerio DA, Georgetti SR, Magro DA, Casagrande R, Cunha TM, Vicentini FT, Vieira SM, Fonseca MJ, Ferreira SH, Cunha FQ, Verri WA Jr (2009) Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production. J Nat Prod 72:1975–1979CrossRefPubMed Valerio DA, Georgetti SR, Magro DA, Casagrande R, Cunha TM, Vicentini FT, Vieira SM, Fonseca MJ, Ferreira SH, Cunha FQ, Verri WA Jr (2009) Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production. J Nat Prod 72:1975–1979CrossRefPubMed
30.
Zurück zum Zitat Vanhees K, van Schooten FJ, van Waalwijk van Doorn-Khosrovani SB, van Helden S, Munnia A, Peluso M, Briede JJ, Haenen GR, Godschalk RW (2013) Intrauterine exposure to flavonoids modifies antioxidant status at adulthood and decreases oxidative stress-induced DNA damage. Free Radic Biol Med 57:154–161CrossRefPubMed Vanhees K, van Schooten FJ, van Waalwijk van Doorn-Khosrovani SB, van Helden S, Munnia A, Peluso M, Briede JJ, Haenen GR, Godschalk RW (2013) Intrauterine exposure to flavonoids modifies antioxidant status at adulthood and decreases oxidative stress-induced DNA damage. Free Radic Biol Med 57:154–161CrossRefPubMed
31.
Zurück zum Zitat Yowtak J, Lee KY, Kim HY, Wang J, Kim HK, Chung K, Chung JM (2011) Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release. Pain 152:844–852CrossRefPubMedPubMedCentral Yowtak J, Lee KY, Kim HY, Wang J, Kim HK, Chung K, Chung JM (2011) Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release. Pain 152:844–852CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Yowtak J, Wang J, Kim HY, Lu Y, Chung K, Chung JM (2013) Effect of antioxidant treatment on spinal GABA neurons in a neuropathic pain model in the mouse. Pain 154:2469–2476CrossRefPubMed Yowtak J, Wang J, Kim HY, Lu Y, Chung K, Chung JM (2013) Effect of antioxidant treatment on spinal GABA neurons in a neuropathic pain model in the mouse. Pain 154:2469–2476CrossRefPubMed
Metadaten
Titel
Effects of quercetin on chronic constriction nerve injury in an experimental rat model
verfasst von
Soner Çivi
Gökçen Emmez
Ümit Akın Dere
Alp Özgün Börcek
Hakan Emmez
Publikationsdatum
09.03.2016
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 5/2016
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-016-2761-0

Weitere Artikel der Ausgabe 5/2016

Acta Neurochirurgica 5/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.